Does the Macrophage Migration Inhibitory Factor in Ascites in patients with ovarian carcinoma effects the prognosis of ovarian carcinoma?

被引：0
|
作者：
Krockenberger, M. [1 ]
Haeusler, S. [1 ]
Engel, J. B. [1 ]
Dietl, J. [1 ]
Hoenig, A. [1 ]
机构：
[1] Univ Frauenklin Wurzburg, Wurzburg, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2009年 / 69卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：750 / 750
页数：1
相关论文
共 50 条
  • [21] Prognostic role of macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the lung
    Koh, Hyun Min
    Kim, Dong Chul
    Kim, Yu-min
    Song, Dae Hyun
    THORACIC CANCER, 2019, 10 (12) : 2209 - 2217
  • [22] The use of bevacizumab to palliate symptomatic ascites in patients with refractory ovarian carcinoma
    Numnum, T. Michael
    Rocconi, Rodney P.
    Whitworth, Jenny
    Barnes, Mack N.
    GYNECOLOGIC ONCOLOGY, 2006, 102 (03) : 425 - 428
  • [23] CYTOLOGIC FINDINGS OF ASCITES IN PATIENTS WITH OVARIAN CLEAR CELL-CARCINOMA
    NISHIDA, M
    KANEKO, M
    YOSHIDA, T
    ACTA CYTOLOGICA, 1981, 25 (01) : 52 - 52
  • [24] Prognostic role of macrophage migration inhibitory factor in patients with clear cell renal cell carcinoma
    An, Hyo Jung
    Koh, Hyun Min
    Lee, Jong Sil
    Song, Dae Hyun
    MEDICINE, 2020, 99 (50) : E23277
  • [25] TREATMENT OF ASCITES USING THE TUMOR-NECROSIS-FACTOR IN OVARIAN-CARCINOMA
    KAUFMANN, M
    SCHMID, H
    RAETH, U
    GRISCHKE, EM
    KEMPENI, J
    SCHLICK, E
    BASTERT, G
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1990, 50 (09) : 678 - 682
  • [26] Reduced bikunin gene expression as a factor of poor prognosis in ovarian carcinoma
    Tanaka, Y
    Kobayashi, H
    Suzuki, M
    Kanayama, N
    Suzuki, M
    Yamakawa, T
    Morishita, H
    Terao, T
    CANCER, 2003, 98 (02) : 424 - 430
  • [27] Does Macrophage Migration Inhibitory Factor predict the prognosis of COVID-19 disease?
    Dheir, Hamad
    Yaylaci, Selcuk
    Sipahi, Savas
    Genc, Ahmed Cihad
    Cekic, Deniz
    Tuncer, Fatma Betul
    Cokluk, Erdem
    Kocayigit, Havva
    Genc, Ahmed Bilal
    Salihi, Salih
    Varim, Ceyhun
    Karabay, Oguz
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2021, 15 (03): : 398 - 403
  • [28] Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis; relevance to pathogenesis
    Akbar, SMF
    Abe, M
    Murakami, H
    Tanimoto, K
    Kumagi, T
    Yamashita, Y
    Michitaka, K
    Horiike, N
    Onji, M
    CANCER LETTERS, 2001, 171 (02) : 125 - 132
  • [29] Ascites in Ovarian Carcinoma - Reliability and Limitations of Cytological Analysis
    Zivadinovic, R.
    Petric, A.
    Krtinic, D.
    Milosevic, J. Stevanovic
    Dinic, S. Pop Trajkovic
    WEST INDIAN MEDICAL JOURNAL, 2015, 64 (03): : 236 - 240
  • [30] Cirrhotic ascites, ovarian carcinoma, and CA-125
    Rubin, J
    Rockey, DC
    SOUTHERN MEDICAL JOURNAL, 1999, 92 (02) : 248 - 250
12345